Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,036 | 22,367 | 37,483 | 45,981 | 56,542 |
| Depreciation Amortization | 27 | 325 | 259 | 173 | 87 |
| Accounts payable and accrued liabilities | 2,390 | -3,428 | -3,032 | -3,236 | -1,379 |
| Other Working Capital | -3,054 | -8,728 | -7,740 | -6,065 | -5,260 |
| Other Operating Activity | -559 | 19,078 | 9,431 | 7,398 | 3,420 |
| Operating Cash Flow | $-10,232 | $29,614 | $36,401 | $44,251 | $53,410 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 27 | 24 | 23 | 13 |
| Purchase Of Investment | 0 | -164,026 | -128,123 | -113,212 | -23,466 |
| Sale Of Investment | 19,500 | 119,094 | 86,083 | 62,583 | 32,000 |
| Investing Cash Flow | $19,500 | $-44,905 | $-42,016 | $-50,606 | $8,547 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -185 | -146 | 50 | -84 | 32 |
| Financing Cash Flow | $-185 | $-146 | $50 | $-84 | $32 |
| Beginning Cash Position | 21,819 | 37,256 | 37,256 | 37,256 | 37,256 |
| End Cash Position | 30,902 | 21,819 | 31,691 | 30,817 | 99,245 |
| Net Cash Flow | $9,083 | $-15,437 | $-5,565 | $-6,439 | $61,989 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,232 | 29,614 | 36,401 | 44,251 | 53,410 |
| Free Cash Flow | -10,232 | 29,614 | 36,401 | 44,251 | 53,410 |